Cara Therapeutics, Inc. (CARA)
NASDAQ: CARA · Real-Time Price · USD
0.305
-0.005 (-1.58%)
At close: Nov 22, 2024, 4:00 PM
0.304
-0.001 (-0.43%)
After-hours: Nov 22, 2024, 4:22 PM EST
Cara Therapeutics Employees
Cara Therapeutics had 55 employees as of December 31, 2023. The number of employees decreased by 51 or -48.11% compared to the previous year.
Employees
55
Change (1Y)
-51
Growth (1Y)
-48.11%
Revenue / Employee
$157,927
Profits / Employee
-$1,736,818
Market Cap
16.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Marinus Pharmaceuticals | 166 |
Nephros | 31 |
Cognition Therapeutics | 28 |
NeuroSense Therapeutics | 18 |
Bullfrog AI | 11 |
Innovative Eyewear | 11 |
Aprea Therapeutics | 7 |
Synlogic | 6 |
CARA News
- 5 months ago - These Cara Therapeutics Analysts Are No Longer Bullish: 'We See No Obvious Future Value Drivers' - Benzinga
- 5 months ago - Cara Therapeutics discontinues study on a neurological condition as drug fails - Reuters
- 5 months ago - Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica - GlobeNewsWire
- 6 months ago - Cara Therapeutics Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024 - GlobeNewsWire
- 8 months ago - Cara Therapeutics, Inc. (CARA) to Present at the 23rd Annual Needham Virtual Healthcare Conference - MarijuanaStocks
- 8 months ago - Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 9 months ago - Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024 - GlobeNewsWire